Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01901094

Recruitment Status : Active, not recruiting

First Posted : July 17, 2013

Last Update Posted : February 26, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

National Cancer Institute (NCI)

Canadian Cancer Trials Group

Information provided by (Responsible Party):

Alliance for Clinical Trials in Oncology

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	January 1, 2025
Estimated Study Completion Date :	January 1, 2025

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ditsch N, Rubio IT, Gasparri ML, de Boniface J, Kuehn T. Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019. Curr Opin Obstet Gynecol. 2020 Feb;32(1):91-99. doi: 10.1097/GCO.0000000000000593.

Mamounas ET. Optimal Management of the Axilla: A Look at the Evidence. Adv Surg. 2016 Sep;50(1):29-40. doi: 10.1016/j.yasu.2016.03.003. Epub 2016 Jun 9. No abstract available.

To Top